Bioavailable oral dosage form of cefuroxime axetil
US6323193A · kind A · utility
13Cited by
5References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 21, 2000 |
| Grant date | Nov 27, 2001 |
| Priority date | — |
| Expiry date | Aug 21, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2095
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a bioavailable oral dosage form comprising of amorphous cefuroxime axetil containing from 7 to 25% crystalline cefuroxime axetil.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.